Successful Use of Pembrolizumab to Treat Refractory Thymic Carcinoma with High PD-L1 Expression
Thymic carcinoma is a relatively rare and aggressive thymic epithelial tumor. Herein, we report successful treatment of thymic carcinoma with pembrolizumab. A 68-year-old woman was admitted to our hospital for evaluation of chest pain. Chest computed tomography showed a mass in the anterior mediasti...
Guardado en:
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Karger Publishers
2018-10-01
|
| Colección: | Case Reports in Oncology |
| Materias: | |
| Acceso en línea: | https://www.karger.com/Article/FullText/493187 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|